Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Norris Medicines Ltd held a meeting on September 1, 2025, and approved several items. These include the Directors' Report and the 34th Annual Report for FY 2024-25. The Board fixed Monday, September 29, 2025, as the date for the 34th Annual General Meeting (AGM), to be held via Video Conferencing or Other Audio-Visual Means. The Register of Members and Share Transfer Books will be closed for the AGM, and a cut-off date was set for shareholders eligible to vote electronically. The Board also appointed Mr. Hemant Shetye (with Mr. Kunal Sakpal as alternate) as Scrutinizer and Purva Sharegistry (India) Pvt. Ltd. as the e-voting facilitator.
This is largely a routine, administrative filing to set up the company's 34th AGM. The new appointments of M/s. Dhiren Y Parikh & Co. as Internal Auditors for FY 2025-26 and M/s HSPN Associates and LLP as Secretarial Auditors for FY 2025-26 to FY 2029-30 are multi-year commitments, but contain no material business or financial impact for shareholders.